Spectral ai adds three new clinical trial sites to expedite emergency department patient enrollment

Dallas, july 23, 2024 (globe newswire) -- spectral ai, inc. (nasdaq: mdai) (“spectral ai” or the “company”), an artificial intelligence (ai) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has added three new u.s. clinical trial sites for its 2024 burn pivotal study: university medical center (umc) burn center at texas tech university health sciences center led by principal investigator alan pang, m.d., tampa general hospital burn center led by principal investigator jared troy, m.d., and university of south alabama (usa) health emergency department led by andrew bright, d.o.
MDAI Ratings Summary
MDAI Quant Ranking